A Science Publishing Revolution

Scientists and publishers generally agree that the Internet is sparking a science publishing revolution.1 They have yet to agree, however, on how to cultivate that revolution without alienating one another. The latest effort to push the online publishing envelope has a sizable group of scientists threatening to boycott journals whose content is not freely available in a public database six months after publication. This call for a "public library of science" (PLOS) has already caused quite a sti

Written byEugene Russo
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The initiative was started late last year by an advocacy group of scientists including Michael Ashburner of the University of Cambridge, Patrick O. Brown of Stanford University, Michael B. Eisen of Lawrence Berkeley National Laboratory and the University of California, Berkeley, Richard J. Roberts of New England Biolabs, Matthew Scott of Stanford, and Harold Varmus of the Memorial Sloan-Kettering Cancer Center. Frustrated with the rate at which journals were agreeing to put journal content into PubMed Central (PMC) (a National Library of Medicine (NLM)-sponsored public research repository that went online in January 2000), the researchers circulated an open letter, at first informally then on the Web (www.publiclibraryofscience.org).

The letter contends that the "full contents of the published record" should belong to the public and not to journal publishers. Publishers are asked to make their content not only available for free on their own Web site, but on that of any ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies